Cargando…

Inhibition of MUC1‐C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is one of the most common digestive tumors worldwide. The Mucin 1 (MUC1) heterodimeric protein has been confirmed that is overexpressed in ESCC and induced adverse outcomes. However, the detailed mechanism(s) remained challenging. So, we investigated the rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	GongSun, Xin, Zhao, YongQiang, Jiang, Bin, Xin, ZhongWei, Shi, Mo, Song, Liang, Qin, QiMing, Wang, Qiang, Liu, XiangYan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587484/ https://www.ncbi.nlm.nih.gov/pubmed/30523643 http://dx.doi.org/10.1002/jcp.27863

Ejemplares similares

Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma
por: Xin, Zhongwei, et al.
Publicado: (2018)

Blocking FGFR4 exerts distinct anti‐tumorigenic effects in esophageal squamous cell carcinoma
por: Xin, Zhongwei, et al.
Publicado: (2018)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
por: Zhao, Yong-Qiang, et al.
Publicado: (2021)

CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1
por: Shi, Mo, et al.
Publicado: (2015)

Downregulation of fibulin‐4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt‐mTOR signaling pathway
por: Chen, Xiangyu, et al.
Publicado: (2022)

Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway
por: Huang, Han-Ming, et al.
Publicado: (2022)

Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis
por: Wang, Qiang, et al.
Publicado: (2019)

Clinical and prognostic significance of MUC1 expression in patients with esophageal squamous cell carcinoma after radical resection
por: Sun, Zhi-Gang, et al.
Publicado: (2018)

Retraction Note to: Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway
por: Huang, Han-Ming, et al.
Publicado: (2022)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma
por: Lin, Shuye, et al.
Publicado: (2021)

MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells
por: Zhang, Ai-Min, et al.
Publicado: (2019)

Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis
por: Yu, Shao-Bin, et al.
Publicado: (2017)

Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway
por: Lu, Yun-Xin, et al.
Publicado: (2016)

Development of an Empirically Calibrated Model of Esophageal Squamous Cell Carcinoma in High-Risk Regions
por: Wang, Zhenhua, et al.
Publicado: (2019)

Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma
por: Wang, Dong, et al.
Publicado: (2017)

HO-1/EBP interaction alleviates cholesterol-induced hypoxia through the activation of the AKT and Nrf2/mTOR pathways and inhibition of carbohydrate metabolism in cardiomyocytes
por: Jin, Xiaohan, et al.
Publicado: (2017)

Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Zhang, Jipeng, et al.
Publicado: (2022)

MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1
por: Mao, Yu, et al.
Publicado: (2016)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

BRE Promotes Esophageal Squamous Cell Carcinoma Growth by Activating AKT Signaling
por: Jin, Fujun, et al.
Publicado: (2020)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
por: Li, Bin, et al.
Publicado: (2017)

ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy
por: Wang, Tianxiao, et al.
Publicado: (2023)

Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
por: Zhao, Lili, et al.
Publicado: (2022)

Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations()
por: Wang, Fengling, et al.
Publicado: (2019)

Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
por: Tang, Hong, et al.
Publicado: (2017)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Qiu, Bo, et al.
Publicado: (2017)

Prognostic Significance of Glasgow Prognostic Score in Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K
por: Zhu, Lili, et al.
Publicado: (2020)

A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma
por: Mao, Yu, et al.
Publicado: (2018)

LncRNA PTCSC3 inhibits cell proliferation in laryngeal squamous cell carcinoma by down-regulating lncRNA HOTAIR
por: Xiao, Dong, et al.
Publicado: (2019)

Downregulation of Ubiquitin Inhibits the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma
por: Gao, Yi, et al.
Publicado: (2020)

Exploration of gene functions for esophageal squamous cell carcinoma using network-based guilt by association principle
por: Wu, Wei, et al.
Publicado: (2018)

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
por: Tang, Hong, et al.
Publicado: (2016)

MUC21 induces the viability and migration of glioblastoma via the STAT3/AKT pathway
por: Wang, Leibo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nudcpt5lp2oobgutjlnu9uahsv